MSLP.Q Stock Overview
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
MusclePharm Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.095 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -99.96% |
3 Year Change | -100.00% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
MSLP.Q | US Personal Products | US Market | |
---|---|---|---|
7D | 0% | -5.0% | 1.6% |
1Y | -100.0% | -26.0% | 25.1% |
Return vs Industry: MSLP.Q underperformed the US Personal Products industry which returned -25.4% over the past year.
Return vs Market: MSLP.Q underperformed the US Market which returned 23.9% over the past year.
Price Volatility
MSLP.Q volatility | |
---|---|
MSLP.Q Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 8.7% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MSLP.Q has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MSLP.Q's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | n/a | Ryan Drexler | www.musclepharm.com |
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.
MusclePharm Corporation Fundamentals Summary
MSLP.Q fundamental statistics | |
---|---|
Market cap | US$33.00 |
Earnings (TTM) | -US$19.26m |
Revenue (TTM) | US$50.02m |
0.0x
P/S Ratio0.0x
P/E RatioIs MSLP.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MSLP.Q income statement (TTM) | |
---|---|
Revenue | US$50.02m |
Cost of Revenue | US$46.83m |
Gross Profit | US$3.19m |
Other Expenses | US$22.45m |
Earnings | -US$19.26m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did MSLP.Q perform over the long term?
See historical performance and comparison